Fate Therapeutics (FATE) logo

FATE earnings date, and what happened the last 4 times

Next report

Thu Nov 12

Quality Score today 2

Before the open, in 17 days. Expected: the company has not confirmed it.

FATE closed higher after 1 of its last 4 reports. On average it closed -2.9% the session after a report.

The moment FATE reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when FATE reports, with its figures

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

What happened after FATE's last 4 reports

FATE's last 4 earnings reports
ReportedScore
going in
GapReaction
Aug 13, 20262026 · Before open4estimated+4.0%-7.3%
May 13, 20262026 · Before open3estimated-2.7%-5.1%
Feb 26, 20262026 · Before open-2estimated-1.4%+5.4%
Nov 13, 20252025 · Before open-9estimated0.0%-4.6%
  • Aug 13, 2026, before the open: that session FATE opened +4.0% and closed -7.3%, and five sessions on it stood -2.6%. Its Quality Score going in was 4 (Below Average), estimated.
  • May 13, 2026, before the open: that session FATE opened -2.7% and closed -5.1%, and five sessions on it stood -16.0%. Its Quality Score going in was 3 (Below Average), estimated.
  • Feb 26, 2026, before the open: that session FATE opened -1.4% and closed +5.4%, and five sessions on it stood -2.0%. Its Quality Score going in was -2 (Poor), estimated.
  • Nov 13, 2025, before the open: that session FATE opened 0.0% and closed -4.6%, and five sessions on it stood +1.0%. Its Quality Score going in was -9 (Poor), estimated.

Across these 4 reports FATE opened higher after 1 of 4 and closed higher after 1 of 4; on average it opened +0.0%, closed -2.9%, and stood -4.9% five sessions on. Its Quality Score is 2 today, against 4 going into its Aug 13, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: -7.3% after the Aug 13, 2026 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see FATE's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about FATE's earnings

As of Oct 26, 2026: Fate Therapeutics (FATE): expected to report Thu Nov 12, before the open. FATE closed higher after 1 of its last 4 reports. Its Quality Score is 2 (Below Average). Scores as of 11:11 PM ET, 15 minutes behind.

When is FATE's next earnings date?

Expected to report Thu Nov 12, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. FATE closed higher after 1 of its last 4 reports. Past behavior, not a forecast.

Does FATE report before or after the market?

FATE is expected to report Thu Nov 12, before the open. Its last 4 reports came before the open.

How did FATE stock react to its last earnings report?

Aug 13, 2026, before the open: that session FATE opened +4.0% and closed -7.3%, and five sessions on it stood -2.6%.

Does FATE stock usually go up after earnings?

FATE closed higher after 1 of its last 4 reports. On average it closed -2.9% the session after a report, after opening +0.0%. Past behavior, not a forecast.

Fate Therapeutics' page has its Quality Score, its chart, and its insiders' trades. Who reports this week: the earnings calendar.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.